ABSTRACT
Endogenous molecules released from disrupted cells and extracellular matrix degradation products activate Toll-like receptors (TLRs) and, thus, might contribute to immune activation after tissue injury. Here, we show that aseptic, cold-induced cortical injury triggered an acute immune response that involves increased production of multiple cytokines/chemokines accompanied by neutrophil recruitment to the lesion site. We observed selective reductions in injury-induced cytokine/chemokine expression as well as in neutrophil accumulation in mice lacking the common TLR signaling adaptor MyD88 compared with wild-type mice. Notably, attenuation of the immune response was paralleled by a reduction in lesion size. Neutrophil depletion of wild-type mice and transplantation of MyD88-deficient bone marrow into lethally irradiated wild-type recipients had no substantial impact on injury-induced expression of cytokines/chemokines and on lesion development. In contrast to MyD88 deficiency, double deficiency of TLR2 and TLR4 -- despite the two receptors being activated by specific endogenous molecules associated to danger and signal through MyD88 -- altered neither immune response nor extent of tissue lesion size on injury. Our data indicate modulation of the neuroinflammatory response and lesion development after aseptic cortical injury through MyD88-dependent but TLR2/4-independent signaling by central nervous system resident nonmyeloid cells.
Subject(s)
Brain Injuries/genetics , Brain Injuries/immunology , Immunity, Cellular/genetics , Myeloid Differentiation Factor 88/genetics , Toll-Like Receptor 2/physiology , Toll-Like Receptor 4/physiology , Animals , Chemokines/metabolism , Cold Temperature , Cytokines/metabolism , Inflammation/genetics , Inflammation/immunology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Neutrophils/immunologyABSTRACT
Recent studies have suggested an important role for the B-cell-attracting chemokine CXCL13 in the B-cell-dominated cerebrospinal fluid (CSF) infiltrate in patients with neuroborreliosis (NB). High levels of CXCL13 were present in the CSF of NB patients. It has not been clear, however, whether high CSF CXCL13 titers are specific for NB or are a characteristic of other spirochetal diseases as well. Furthermore, the mechanisms leading to the observed CXCL13 expression have not been identified yet. Here we describe similarly elevated CSF CXCL13 levels in patients with neurosyphilis, while pneumococcal meningitis patient CSF do not have high CXCL13 levels. In parallel, challenge of human monocytes in vitro with two of the spirochetal causative organisms, Borrelia garinii (the Borrelia species most frequently found in NB patients) and Treponema pallidum, but not challenge with pneumococci, induced CXCL13 release. This finding implies that a common spirochetal motif is a CXCL13 inducer. Accordingly, we found that the lipid moiety N-palmitoyl-S-(bis[palmitoyloxy]propyl)cystein (Pam(3)C) (three palmitoyl residues bound to N-terminal cysteine) of the spirochetal lipoproteins is critical for the CXCL13 induction in monocytes. As the Pam(3)C motif is known to signal via Toll-like receptor 2 (TLR2) and an anti-TLR2 monoclonal antibody blocked CXCL13 production of human monocytes incubated with B. garinii, this suggests that TLR2 is a major mediator of Borrelia-induced secretion of CXCL13 from human monocytes.
Subject(s)
Borrelia burgdorferi Group/immunology , Chemokines, CXC/biosynthesis , Chemokines, CXC/genetics , Gene Expression Regulation, Bacterial/immunology , Monocytes/immunology , Monocytes/microbiology , Toll-Like Receptor 2/physiology , Adult , Amino Acid Sequence , Animals , Cell Line , Chemokine CXCL13 , Chemokines, CXC/cerebrospinal fluid , Chemokines, CXC/metabolism , Female , Humans , Lyme Neuroborreliosis/immunology , Lyme Neuroborreliosis/metabolism , Lyme Neuroborreliosis/microbiology , Male , Mice , Mice, Inbred C3H , Middle Aged , Molecular Sequence Data , Monocytes/metabolismABSTRACT
Hearing loss is one of the most common sequelae in survivors of pneumococcal meningitis, affecting up to 26% of them. Here, we established the first mouse model of meningitis-associated hearing loss and investigated the role played by the Toll-like receptor-associated adapter molecule MyD88. C57BL/6 mice were infected intracisternally by Streptococcus pneumoniae. By use of audiometry and histological analysis, cochleae were assessed in uninfected control mice during the acute stage and after recovery. MyD88-deficient mice were analyzed 24 h after infection. Wild-type mice lost hearing capacity to a significant degree, which was accompanied by a granulocytic cochlear inflammation. After recovery, hearing loss was still evident, and spiral ganglion neuronal loss, hair cell damage, and fibrocytic occlusion of the cochlea were observed. In contrast, mice lacking MyD88 developed significantly less hearing loss and had diminished cochlear inflammation. Our results strongly suggest a proinflammatory role for MyD88 in the initiation of the inflammatory response during pneumococcal meningitis-associated labyrinthitis.
Subject(s)
Hearing Loss/etiology , Hearing Loss/immunology , Meningitis, Pneumococcal/complications , Meningitis, Pneumococcal/immunology , Myeloid Differentiation Factor 88/immunology , Animals , Auditory Threshold , Cochlea/microbiology , Disease Models, Animal , Evoked Potentials, Auditory, Brain Stem , Hearing Loss/pathology , Labyrinthitis/complications , Labyrinthitis/immunology , Labyrinthitis/microbiology , Labyrinthitis/pathology , Meningitis, Pneumococcal/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , Myeloid Differentiation Factor 88/genetics , Spiral Ganglion/pathologyABSTRACT
Increased vascular permeability causing vasogenic brain edema is characteristic for many acute neurological diseases such as stroke, brain trauma, and meningitis. Src family kinases, especially c-Src, play an important role in regulating blood-brain barrier permeability in response to VEGF, but also mediate leukocyte function and cytokine signalling. Here we demonstrate that pharmacological inhibition of Src or c-Src deficiency does not influence cerebrospinal fluid (CSF) pleocytosis, brain edema formation, and bacterial outgrowth during experimental pneumococcal meningitis despite the increased cerebral expression of inflammatory chemokines, such as IL-6, CCL-9, CXCL-1, CXCL-2 and G-CSF as determined by protein array analysis. In contrast, inhibition of Src significantly reduced brain edema formation, lesion volume, and clinical worsening in cold-induced brain injury without decreasing cytokine/chemokine expression. While brain trauma was associated with increased cerebral VEGF formation, VEGF levels significantly declined during pneumococcal meningitis. Therefore, we conclude that in brain trauma blood-brain barrier tightness is regulated by the VEGF/Src pathway whereas c-Src does not influence brain edema formation and leukocyte function during bacterial meningitis.
Subject(s)
Blood-Brain Barrier/enzymology , Brain Edema/enzymology , Brain Injuries/enzymology , Cerebral Arteries/enzymology , Meningitis, Pneumococcal/enzymology , src-Family Kinases/metabolism , Animals , Blood-Brain Barrier/microbiology , Blood-Brain Barrier/physiopathology , Brain Edema/microbiology , Brain Edema/physiopathology , Brain Injuries/physiopathology , CSK Tyrosine-Protein Kinase , Cerebral Arteries/microbiology , Cerebral Arteries/physiopathology , Cerebrospinal Fluid/drug effects , Cerebrospinal Fluid/metabolism , Cerebrospinal Fluid Pressure/drug effects , Cerebrospinal Fluid Pressure/physiology , Chemokines/immunology , Chemokines/metabolism , Disease Models, Animal , Down-Regulation/drug effects , Down-Regulation/physiology , Encephalitis/immunology , Encephalitis/physiopathology , Enzyme Inhibitors/pharmacology , Meningitis, Pneumococcal/physiopathology , Mice , Mice, Inbred C57BL , Protein-Tyrosine Kinases/antagonists & inhibitors , Protein-Tyrosine Kinases/metabolism , Proto-Oncogene Proteins pp60(c-src)/antagonists & inhibitors , Proto-Oncogene Proteins pp60(c-src)/metabolism , Vascular Endothelial Growth Factor A/immunology , Vascular Endothelial Growth Factor A/metabolism , src-Family Kinases/antagonists & inhibitorsABSTRACT
In this study, we investigated cytokine expression during experimental pneumococcal meningitis. Mice were intracisternally infected with Streptococcus pneumoniae and treated with ceftriaxone starting at 24 h after infection. At different time points before and after antibiotic therapy, the cytokine expression pattern was determined in mouse brains using protein arrays. Underlining the power of this method, the meningitis-relevant cytokines interleukin-1beta (IL-1beta), IL-6, KC, macrophage inflammatory protein-2 (MIP-2), and monocyte chemoattractant protein-1 (MCP-1/CCL2) were markedly elevated in infected animals. Newly identified proteins during the acute stage of the disease (until 30 h after infection) included lymphotactin (XCL-1), MIP-1gamma (CCL9) and MCP-5 (CCL12), cytokine responsive gene- 2 (CRG-2/CXCL10) and CXCL16, and insulin-like growth factor binding protein 3 (IGFBP3). During later stages, an induction of T-cell activation-3 (TCA-3/CCL1), platelet factor-4 (PF-4/CXCL4) and stromal derived factor-1alpha (SDF-1alpha/CXCL13), and IL-4 was observed. The validity of this method was supported by an additional ELISA analysis of the expression profile of CXCL16 and IGFBP3, which was identical to that observed by protein array. In conclusion, the use of protein array technology led to an extension of the current picture of protein expression in pneumococcal meningitis. Most important, new factors that might play a role in pneumococcal meningitis were identified.
Subject(s)
Brain/metabolism , Chemokines, C/biosynthesis , Macrophage Inflammatory Proteins/biosynthesis , Meningitis, Pneumococcal/metabolism , Monocyte Chemoattractant Proteins/biosynthesis , Monokines/biosynthesis , Platelet Factor 4/biosynthesis , Streptococcus pneumoniae , Animals , Anti-Bacterial Agents/therapeutic use , Brain/immunology , Ceftriaxone/therapeutic use , Chemokine CXCL10 , Chemokine CXCL13 , Chemokines, CC , Chemokines, CXC/biosynthesis , Cytokines/biosynthesis , Disease Models, Animal , Interleukin-4/biosynthesis , Meningitis, Pneumococcal/drug therapy , Mice , Mice, Inbred C57BL , Protein Array Analysis , Time FactorsABSTRACT
Tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA) have been suggested to play an important role in inflammatory diseases. Increased levels of tPA, uPA, uPA receptor (uPAR), and their inhibitor, plasminogen activator inhibitor (PAI)-1, have been found in the cerebrospinal fluid (CSF) of patients with bacterial meningitis. Here, we show that expression of tPA, uPA, uPAR, PAI-1, and PAI-2 is up-regulated during experimental pneumococcal meningitis. In uPAR-deficient mice, CSF pleocytosis was significantly attenuated 24 h after infection, compared with that in infected wild-type (wt) mice. Lack of uPAR did not influence blood-brain barrier permeability, intracranial pressure, expression of chemokines (keratinocyte-derived cytokine and macrophage inflammatory protein-2), bacterial killing, or clinical outcome. No differences in pathophysiological alterations were observed in tPA-deficient mice, compared with those in infected wt mice. These results indicate that uPAR participates in the recruitment of leukocytes to the CSF space during pneumoccal meningitis.